Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis

被引:9
作者
Pavan, Karina
Marangoni, Bruna E. M.
Schmidt, Kizi B.
Cobe, Femanda A.
Matuti, Gabriela S.
Nishino, Lucia K.
Thomaz, Rodrigo B.
Mendes, Maria Fernanda
Lianza, Sergio
Tilbery, Charles Peter
机构
[1] Irmandade Santa Casa Misericordia Sao Paulo, Grp Reabil Neurol, Sao Paulo, SP, Brazil
[2] ISCMSP, Fisioterapia Neuro Func, Sao Paulo, SP, Brazil
[3] ISCMSP, Fonoaudiol Setor Otorrinolaringologia, Sao Paulo, SP, Brazil
[4] Univ Fed Sao Paulo, Sao Paulo, Brazil
[5] SCMSP, Fac Ciencias Med, Sao Paulo, Brazil
关键词
multiple sclerosis; vertigo; rehabilitation;
D O I
10.1590/S0004-282X2007000200027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple sclerosis (MS) is a demyelinating, inflammatory illness, that attack the white matter of the central nervous system, and abnormal vestibular sensations (vertigo, disequilibrium) are frequent. The vestibular rehabilitation (VR) is determined by mechanisms of adaptations, neural substitutions and compensations. This study evaluated the improvement of the central or peripheral vertigo in patients with relapsing-remitting MS submitted to the VR (exercises of Cawthorne-Cooksey), through the scale of Berg and Dizziness Handicap Inventory (DHI). In this sample of 4 cases the VR, carried through in a period of 2 months, demonstrated the improvement in 3 patients according to the Berg scale and in 2 patients considering that of the DHI.
引用
收藏
页码:332 / 335
页数:4
相关论文
共 50 条
  • [21] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    Buscarinu, M. C.
    Romano, S.
    Mechelli, R.
    Umeton, R. Pizzolato
    Ferraldeschi, M.
    Fornasiero, A.
    Renie, R.
    Cerasoli, B.
    Morena, E.
    Romano, C.
    Loizzo, N. D.
    Umeton, R.
    Salvetti, M.
    Ristori, G.
    NEUROTHERAPEUTICS, 2018, 15 (01) : 68 - 74
  • [22] PROGNOSIS OF DISABILITY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Somilo, O., V
    Kalbus, O., I
    Makarov, S. O.
    Sorokin, A. V.
    Shastun, N. P.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 84 (02): : 147 - 152
  • [23] Executive functions in relapsing-remitting multiple sclerosis
    Elosua, M. Rosa
    Villadangos, Noelia
    APPLIED NEUROPSYCHOLOGY-ADULT, 2023,
  • [24] Resistance Training in Relapsing-Remitting Multiple Sclerosis
    Dalgas, U.
    Kant, M.
    Stenager, E.
    AKTUELLE NEUROLOGIE, 2010, 37 (05) : 213 - 218
  • [25] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [26] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, Rita
    Rocha, Raquel
    Bonifacio, Goncalo
    Ferro, Daniela
    Sabenca, Francisco
    Goncalves, Ana Isabel
    Correia, Filipe
    Pinheiro, Joaquim
    Loureiro, Jose Leal
    Guerreiro, Rui Pedro
    Vale, Jose
    Sa, Maria Jose
    Costa, Andreia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [27] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [28] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [29] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [30] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139